Compass Lexecon throws its weight into some of the world’s biggest competition cases, both mergers and conduct.
- Involved in 198 merger-related matters
- 374 competition economists
- Many lateral hires and internal promotions across the firm’s offices
|Global heads||Daniel Fischel, Jonathan Orszag, Mark Israel, Jorge Padilla|
|Total size of firm||473|
|% of firm specialised||79%|
|Who’s Who Legal: Competition nominees||33|
Compass Lexecon saw a lot of change this past year, hiring nine people to senior positions within the firm. Three competition economists joined the firm as vice presidents – Daniela Bambaci in Houston, Aleksandra Boutin and Xavier Boutin in Brussels, and Matthias Pflanz and former OECD competition head John Davies in London. Damien Neven joined as a senior consultant in Brussels; Derek Ritzmann as senior vice president in Hong Kong; and Elizabeth Wang as senior vice president in Boston. The 13 promotions took place across the firm’s US and London offices, including four to the executive vice president level.
Companies hire Compass Lexecon to work on some of the biggest, most complex mergers around the globe, including Aetna/Humana, Anthem/Cigna, Sysco/US Foods, Expedia/Orbitz, Alaska Airlines/Virgin America, Agrium/Potash Corporation of Saskatchewan, Dell/EMC, AT&T/DirectTV, Siemens/Dresser-Rand and BT/EE.
In antitrust litigation, Compass Lexecon worked on a wide variety of major price-fixing and antitrust class action matters, such as Southeastern Milk, NCAA Athletic Grant-in-Aid Cap; and liquid-crystal-display and and cathode-ray-tube follow-on damages claims. In the Wellbutrin XL pay-for-delay case, senior consultant Robert Willig testified on behalf of GlaxoSmithKline that there was no likely anticompetitive delay to entry and that the reverse-payment settlement was procompetitive.